Sign in
4

Changes in Ownership

NOVAVAX INC Filed Acc 0001209191-21-047809

President, R&D sold 2,409 shares at an average $215.43 ($518,982)

From the SEC's structured data for this filing

Trades in this filing

Glenn Gregory M · President, R&D

Table I: Non-derivative

18 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-20 Sale : show line 1 in the form −119 $200.61 $23,872 5,101 D
2021-07-20 Sale : show line 2 in the form −199 $202.76 $40,348 4,902 D
2021-07-20 Sale : show line 3 in the form −61 $203.39 $12,407 4,841 D
2021-07-20 Sale : show line 4 in the form −119 $204.71 $24,360 4,722 D
2021-07-20 Sale : show line 5 in the form −181 $205.66 $37,225 4,541 D
2021-07-20 Sale : show line 6 in the form −135 $206.82 $27,920 4,406 D
2021-07-20 Sale : show line 7 in the form −126 $207.63 $26,161 4,280 D
2021-07-20 Sale : show line 8 in the form −63 $211.93 $13,352 4,217 D
Open-market sales · 2,409 sh · avg $215.43 · $518,982
Loading xslF345X03/doc4.xml…